Hebrew University student develops method to check if AIDS patients developed resistance to drugs
Ph.D. candidate Lital Alfonta wins Kaye Award
Lital Alfonta, a Ph.D. candidate in the Faculty of Science at the Hebrew University of Jerusalem, has developed a fast, inexpensive test to determine if an AIDS patient has developed resistance to the medication he is taking. Ms. Alfonta was selected to receive the prestigious Kaye Innovation Award for her work, which could vastly improve treatment of AIDS patients.
Ms. Alfonta, who developed the test under the guidance of Prof. Itamar Willner, of the Institute of Chemistry, and Professor of Molecular Virology Moshe Kotler, explained that the AIDS virus changes as the disease progresses and often becomes immune to the medications being used against it. However, the existing tests to check if a medicine is no longer effective because the virus is immune to it take three to four weeks to conduct and cost thousands of dollars, beyond the means of most AIDS patients. More importantly, those few weeks that it takes to evaluate the test results could be the difference between life and death in treating an AIDS patient.
The test Ms. Alfonta developed can be evaluated within 24 hours and will cost as little as $100 to conduct, she said. It also is more sophisticated than current tests and the results will indicate what type of medication should be used to treat the patient. In addition, pharmaceutical companies can use it to evaluate AIDS medication during its development.
Ms. Alfonta, who is receiving an Eshkol fellowship from the Ministry of Science, made this important breakthrough in AIDS research during her Ph.D. research in bioelectronics in Prof. Willner’s lab. They are working on converting biological interactions of DNA into electronic signals and were looking for a sophisticated group of interactions to study. Prof. Kotler, who conducts AIDS research at the Faculty of Medicine, suggested that she study interactions involving the AIDS virus. Less than a year after she began working on this project, Ms. Alfonta made a significant contribution to Prof. Willner’s work in bioelectronics and to AIDS research.
Prof. Wilner said that they have filed an application to patent the test and are exploring commercial options to further develop and produce it.
The Kaye Innovation Awards at the Hebrew University have been awarded annually since 1994. Isaac Kaye of England, a prominent industrialist in the pharmaceutical industry, established the awards to encourage faculty, staff, and students of the University to develop innovative methods and inventions with good commercial potential which will benefit the University and society. The Kaye Innovation Awards at the Hebrew University are being awarded Tuesday, June 4 at 10:30 a.m. during the 65th meeting of the University Board of Governors. The award ceremony will take place in the Atzmaut-Mexico Hall in the Faculty of Humanities at the Mount Scopus Campus.
Picture available upon request. For further information, contact:
Heidi Gleit, HU foreign press liaison: tel. 972-2-588-2904; cell, 972-64-454-593; email firstname.lastname@example.org
Orit Sulitzeanu, HU spokeswoman: tel. 972-2-588-2811
Heidi J. Gleit | EurekAlert
The most recent press releases about innovation >>>
Die letzten 5 Focus-News des innovations-reports im Überblick:
Staphylococcus aureus is a feared pathogen (MRSA, multi-resistant S. aureus) due to frequent resistances against many antibiotics, especially in hospital infections. Researchers at the Paul-Ehrlich-Institut have identified immunological processes that prevent a successful immune response directed against the pathogenic agent. The delivery of bacterial proteins with RNA adjuvant or messenger RNA (mRNA) into immune cells allows the re-direction of the immune response towards an active defense against S. aureus. This could be of significant importance for the development of an effective vaccine. PLOS Pathogens has published these research results online on 25 May 2017.
Staphylococcus aureus (S. aureus) is a bacterium that colonizes by far more than half of the skin and the mucosa of adults, usually without causing infections....
Physicists from the University of Würzburg are capable of generating identical looking single light particles at the push of a button. Two new studies now demonstrate the potential this method holds.
The quantum computer has fuelled the imagination of scientists for decades: It is based on fundamentally different phenomena than a conventional computer....
An international team of physicists has monitored the scattering behaviour of electrons in a non-conducting material in real-time. Their insights could be beneficial for radiotherapy.
We can refer to electrons in non-conducting materials as ‘sluggish’. Typically, they remain fixed in a location, deep inside an atomic composite. It is hence...
Two-dimensional magnetic structures are regarded as a promising material for new types of data storage, since the magnetic properties of individual molecular building blocks can be investigated and modified. For the first time, researchers have now produced a wafer-thin ferrimagnet, in which molecules with different magnetic centers arrange themselves on a gold surface to form a checkerboard pattern. Scientists at the Swiss Nanoscience Institute at the University of Basel and the Paul Scherrer Institute published their findings in the journal Nature Communications.
Ferrimagnets are composed of two centers which are magnetized at different strengths and point in opposing directions. Two-dimensional, quasi-flat ferrimagnets...
Nano-hologram paves way for integration of 3-D holography into everyday electronics
An Australian-Chinese research team has created the world's thinnest hologram, paving the way towards the integration of 3D holography into everyday...